By integrating fasting and postprandial evidence across classical and less-studied gut peptides and distinguishing responses to mixed meals and oral glucose challenges, this review provides a physiological framework for interpreting gut hormone dysregulation in obesity and T2DM and for contextualizing emerging multi-agonist incretin therapies. Here, GCG is linked to type 2 diabetes mellitus.